Cme Group Inc.
—Price / book
Market cap
—
Tangible equity (USD)
—
Price / tangible book
—
Price / book
—
Net income / ending equity
14.2%
Net income / ending assets
2.1%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CME stock price vs DNB: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DNB's multiple
Needs DNB P/E.
Implied fair value · at CME's multiple
Needs Annual EPS is negative, CME P/E.
Price unavailable
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Lower is better
Lower is better
Profitability edge
Asset efficiency edge
Lower is better
Statements
Reported bank earnings and balances, with each company’s reporting period shown.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
—
Tangible equity (USD)
—
Price / tangible book
—
Price / book
—
Net income / ending equity
14.2%
Net income / ending assets
2.1%
Efficiency ratio
—
Price / book
Market cap
—
Tangible equity (USD)
-$3.62B
Price / tangible book
—
Price / book
—
Net income / ending equity
-0.9%
Net income / ending assets
-0.3%
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CME GROUP INC. · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Dun & Bradstreet Holdings, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe CME can sustain its high-margin, low-leverage business model, then holding or accumulating CME makes sense because its profitability and balance sheet are materially stronger than DNB’s while the stock still trades within its historical band.
CME trades at $267.79, near the middle of its historical range of $241.01 to $294.57, suggesting the market is not pricing in an extreme premium or discount. On the provided data, the main valuation anchor is CME’s P/E of 24.0x and P/S of 2.7x, while DNB lacks comparable valuation multiples in the dataset.
Supporting Metrics